Abstract INTRODUCTION Real‐world data on lecanemab's efficacy and the longitudinal dynamics of plasma biomarkers are scarce in Chinese patients with Alzheimer's disease (AD). METHODS In this multicenter cohort study, 181 AD patients received biweekly lecanemab. Disease‐stage‐specific Clinical Dementia Rating–Sum of Box...
Limoran Tang, Xi-Chen Chen, Li Zhang et al.· Alzheimer's & Dementia· 0 citations
Background Vestibular migraine (VM) is a leading cause of recurrent vertigo, and many patients describe cognitive symptoms such as “brain fog,” slowed thinking, and forgetfulness; however, the magnitude and consistency of objectively measured cognitive impairment in VM have not been clearly quantified. We therefore con...
Mei-Qi Di, Ling-Ling Hu, Chao-Sheng Li et al.· Frontiers in Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.